JOHNSON & JOHNSON — Director's Dealing 2018

Feb 15, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2018-02-12

Reporting Person: Duato Joaquin (Exec VP, WW Chair, Pharma)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-12	Common Stock	M	24530.0000	$0.0000	Acquired	99210.0000	Direct
2018-02-12	Common Stock	A	8831.0000	$0.0000	Acquired	108041.0000	Direct
2018-02-12	Common Stock	F	14486.0000	$129.5100	Disposed	93555.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-12	Employee Stock Options (Right to Buy)	$129.5100	A	105307.0000	Acquired	2028-02-12	Common Stock (105307.0000)	Direct
2018-02-12	Performance Share Units	$0.0000	M	24530.0000	Disposed		Common Stock (24530.0000)	Direct
2018-02-12	Restricted Share Units	$	A	5283.0000	Acquired		Common Stock (5283.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	602.0000	Indirect

Footnotes

F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

F2: Shares earned due to performance factor of 136% upon vesting of Performance Share Units and certification of performance results by the Board.

F3: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.

F4: Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2018).

F5: Awarded under Issuer's Long-Term Incentive Plan.

F6: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.